Bioceptive is a women’s health company developing innovative products to improve care for women all over the world.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location New Orleans, LA, USA
- Currency USD
- Founded August 2010
- Employees 5
- Website bioceptive.com
Bioceptive is a women’s health company developing innovative products to improve care for women worldwide. Bioceptive has developed a patent-pending intrauterine device (IUD) inserter that revolutionizes the IUD insertion field. Currently, 175 million women use IUDs worldwide and it is increasing by 4.6% annually. Bioceptive has its first 510k of a suction based retractor that replaces tenaculum and forms a basis of creating other devices.
Stewart B. Davis, MDChief Executive Officer & President
Dr. Davis has extensive operational experience working as an executive and/or founder in six medical device start-ups. He has previous experience in gaining FDA and CE Mark clearance for nine devices, has successfully commercialized several of these medical devices, took his last company public and has overseen multiple exits. Additionally, Dr. Davis is experienced in building sales teams and launching full international sales rollouts.
Shuchi P. KhuranaChief Operating Officer
Shuchi "SK" Khurana has fourteen years of experience in various fields including technology commercialization, product management, new product development, business development and marketing. Prior to Bioceptive, he was managing a portfolio of six products and a multi-million dollar R&D program.
SK holds two masters degrees, MBA and MS from The Ohio State University, and a B.Tech. degree from Indian Institute of Technology (IIT) Kanpur.
Benjamin D. CappielloChief Scientific Officer
Benjamin is a biomedical engineer and graduate of Tulane University. He is the inventor of the Bioceptive Inserter.
Ben has done research in the laboratory of the renowned adult stem cell bioengineer, James L. Sherley, MD, PhD, and wrote his thesis, Analysis and Automation of the Quantification of Asymmetric Self Renewal Kinetics of Human Hepatic Stem Cells, based upon his research there.
Graffagnini and Associates ; Cooley LLPLawyerUnconfirmedWegmann Dazet and CompanyAccountantUnconfirmed
First Light VenturesUnconfirmedAbstraction VenturesUnconfirmedTamara KreininUnconfirmed